Work

Vemurafenib in Patients With Relapsed Refractory Multiple Myeloma Harboring BRAFV600 Mutations: A Cohort of the Histology-Independent VE-BASKET Study

Year: 2018

Type: article

Source: JCO Precision Oncology

DOI: 10.1200/po.18.00070

Authors: Noopur Raje, Ian Chau, David M. Hyman, Vincent Ribrag, Jean-Yves Blay, Josep Tabernero, Elena Elez, Jürgen Wolf, Andrew J. Yee, Martin Kaiser, Heather Landau, Jean-Marie Michot, Antoine Hollebecque, Luisa Veronese, Martina Makrutzki, Bethany Pitcher, Igor Puzanov, Jose Baselga

Institutions: Roswell Park Comprehensive Cancer Center, Memorial Sloan Kettering Cancer Center, Institut Gustave Roussy, Massachusetts General Hospital, Centre Léon Bérard, Royal Marsden Hospital

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2889315403

FWCI: 2.331

Cites: 21

Cited by: 37

Related to: 10